CivaTech Oncology
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
104 Dr Taiwan, Durham, North Carolina, 2...Phone Number
(919) 314-5515Website
www.civatechoncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CivaTech Oncology
CivaTech Oncology is a North Carolina-based corporation specializing in innovative polymer-based low dose rate brachytherapy devices for cancer treatment. Their products, including CivaSheet, CivaString, and CivaDerm, are designed to enhance localized radiation therapy by minimizing trauma and improving treatment outcomes. The company targets radiation oncologists and cancer patients, offering customizable solutions that integrate seamlessly into clinical workflows. CivaTech's FDA-cleared devices are aimed at treating various solid tumors, including prostate, pancreatic, and skin cancers.Explore more
CivaTech Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CivaTech Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if CivaTech Oncology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CivaTech Oncology
CivaTech Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if CivaTech Oncology has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once CivaTech Oncology has new funding data
Product Launch: Get notified when CivaTech Oncology launches new products
Earning: See what the market has to say on CivaTech Oncology recently announced quarterly report
Check out if CivaTech Oncology is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to CivaTech Oncology
Compare insights from companies similar to CivaTech Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CivaTech Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CivaTech Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CivaTech Oncology.
CivaTech Oncology financials insights
Gather financial insights about CivaTech Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Private Equity
$700K
2014
Private Equity
$1.5M
2015
Debt
$2.7M
2017
Private Equity
$916K
2020
Debt
$150K
CivaTech Oncology Tech Stack
A closer look at the technologies used by CivaTech Oncology
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Project
Spending/Investment
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
Event
CivaTech Oncology News & Media
Profound Improvement for Pancreatic Cancer Patients Using CivaSheet®, a New Radiation Device
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--CivaTech Oncology Inc., announces CivaSheet® significantly boosts outcomes for borderline resectable and locally advanced pancreatic cancer patients. CivaSheet, an implantable, targeted, shielded radiation device delivers an aggressive dose immediately to the pancreas region following surgical resection. Studies have been conducted in multi-institutional settings, garnering support from the NIH/NCI and SBIR programs. This is the first analysis of oCivaTech Oncology selected to present at BIO International Conference
SAN DIEGO--(BUSINESS WIRE)--CivaTech Oncology presents CivaSheet at Bio International Conference.Cancer Experts Report Initial Findings of CivaSheet® Soft Tissue Sarcoma Registry
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Physicians from four medical centers recently published data this month from an initial six patients implanted with CivaSheet® to treat retroperitoneal sarcoma. The article, titled “Initial Clinical Experience With Novel Directional Low-dose Rate Brachytherapy for Retroperitoneal Sarcoma” was accepted for publication in the Journal of Surgical Research on June 28, 2021. With a mean follow up of 16 months, no local cancer recurrences, no toxicities,CivaTech Oncology and NYU Langone Health Launch NIH-sponsored Trial to Fight Lung Cancer
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Physicians from NYU Langone Health and its Perlmutter Cancer Center successfully treated their first patient in an NIH/NCI- sponsored clinical trial using CivaSheet® ,to improve lung cancer patients’ outcomes. The NYU Langone team, led by thoracic surgeon Michael Zervos, MD and radiation oncologist Benjamin Cooper, MD, affixed a custom sized CivaSheet® to the area of the patient’s lung needing treatment, following a robotic tumor resection. The pat
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CivaTech Oncology
Sign Up For FreeTo access detailed company insights
CivaTech Oncology is a North Carolina-based corporation specializing in innovative polymer-based low dose rate brachytherapy devices for cancer treatment. Their products, including CivaSheet, CivaString, and CivaDerm, are designed to enhance localized radiation therapy by minimizing trauma and improving treatment outcomes. The company targets radia... Read More
